VIDEO: SABCS presentations update practice-informing studies
Click Here to Manage Email Alerts
In this video, Megan Kruse, MD, a breast medical oncologist at Cleveland Clinic, discusses the presentations she was most looking forward to at San Antonio Breast Cancer Symposium 2021.
“I think there’s a lot of updates to studies that have informed our practice over the last couple of years,” Kruse said.
She added that two of these include updates to the KEYNOTE-522 trial and the KEYNOTE-355 trial.
Additionally, Kruse noted there will be presentations updating prior studies on CDK4/6 inhibitors, including findings from the PALLAS study.
“It is going to be interesting to get the flush out from that data and to see the final results in the context of the recent FDA approval of abemaciclib in this same space,” Kruse said, adding that “we’re really not quite sure how the CDK4/6 inhibitors are going to fit into our clinical practice for high-risk [hormone receptor]-positive HER2-negative breast cancer patients, and so building on the foundation of knowledge we have right now will be really crucial.”
Collapse
Read more about
Click Here to Manage Email Alerts